|
CONFERENCE ADVISORY
COMMITTEE
CONFERENCE ADVISORY
COMMITTEE CHAIR:
Gordon G. Liu, PhD Chair, ISPOR Asia Consortium
Executive Committee, Professor and Chair, Department
of Health Economics and Management, Guanghua School of
Management, Peking University, Beijing, P.R. China
CONFERENCE ADVISORY COMMITTEE
MEMBERS:
Dongjing Wang, Vice Minister, Ministry of
Labor and Social Security, P.R. China
Xiaoping Zhao, Director General, Department
Price Supervision, National Development and Reform
Commission, P.R. China
Fengxia Lu, Director, Center of Drug Price
Evaluation, National Development and Reform
Commission, P.R. China
Hong Yao, Director General, Department of Health
Insurance, Ministry of Labor and Social Security,
P.R. China
Ianfei Liu, Director General, Department of
Science, Technology and Education, Ministry of
Health, P.R. China
Dezhi Yu, Deputy Director, Department of
Planning and Budgeting, Ministry of Health, P.R.
China
Shifei Chen, Deputy Director, Food and Drug
Administration, Zhejiang Province, P.R. China
Quoming Qi, Vice Chairman, Chinese medical
Association, P.R. China
Jing Yang, President, Chinese Medical Doctor
Association, P.R. China
Feng Han, Chairperson of China Social
Insurance Association Medical Insurance Branch, P.R.
China
Jiyao Wang, President, Chinese Clinical
Epidemiology Society, P.R. China
Renhua Cai, Professor and Honorary Dean,
School of Public Health, Shanghai Jiao Tong
University, P.R. China and Vice Executive President,
Chinese Health Economics Association, P.R. China
Xuejin Zuo, Professor of Economics, Executive
Vice President, Shanghai Academy of Social Sciences,
P.R. China
Donglu Bai, President, Shanghai
Pharmaceutical Association, P.R. China and
Professor, Shanghai Institute of Material Medical,
Chinese Academy of Sciences, P.R. China
Lihua Sun, PhD, Professor and Dean,
Pharmaceutical Business School, Shenyang
Pharmaceutical University, Shenyang, Liaoning, P.R.
China
Youping Li, Professor, West China Center of
Medical Sciences, Sichuan University, Chengdu,
Sichuan, P.R. China, President, Chinese Cochrane
Center, P.R. China
Jianhong Tao, Deputy Director, South
Medicinal Economical Research Institute, the State
Food and Drug Administration, P.R. China and Editor
in Chief, Medicinal Economics Newspaper, Guangzhou,
Guangdong, P.R. China
Hai Gu, PhD, Professor, International
Pharmaceutical Business School, China Pharmaceutical
University, Nanjing, Jiangsu, P.R. China |
